CompletedPhase 3ACTRN12607000421437

A clinical trial of a tooth cream in the repair of early dental decay.

A three-month, double-blind, parallel-group, placebo-controlled randomized clinical trial to investigate the remineralizing capacity of casein phosphopeptide-amorphous calcium phosphate in a post-orthodontic population.

Sponsor

GC Corporation

Enrollment

46 participants

Start Date

Aug 1, 2006

Study Type

Interventional

Conditions

Caries

Eligibility

Sex: Both males and femalesMin Age: 12 YearssMax Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This study tests a tooth cream designed to help repair early dental decay (white spot lesions) after braces are removed. It is open to people aged 12 to 18 who are finishing orthodontic treatment. Participants will use the cream daily and attend four clinic visits over 12 weeks to check their teeth.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Tooth Mousse (containing casein phosphopeptide-amorphous calcium phosphate nanocomplexes (CPP-ACP). Tooth Mousse contains 10% w/v CPP-ACP. Dosage is 1ml Tooth Mousse twice daily for 12 weeks.

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12607000421437

Related Trials

Post-Debonding Finishing in Orthodontics

NCT075344231 location

Clinical Performance and Acceptance of Bioflx Crowns

NCT066779831 location